• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameRESTOREULTRA RECHARGEABLE IMPLANTABLE NEUROSTIMULATION SYSTEM
Classification Namestimulator, spinal-cord, totally implanted for pain relief
ApplicantMEDTRONIC VASCULAR
PMA NumberP840001
Supplement NumberS097
Date Received05/18/2007
Decision Date01/08/2008
Product Code
LGW[ Registered Establishments with LGW ]
Advisory Committee Neurology
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - component
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the restoreultra rechargeable neurostimulation system. The device is indicated as an aid in the management of chronic, intractable, unilateral or bilateral pain associated with the following: 1) failed back syndrome or low back syndrome or failed back; 2) radicular pain syndrome or radiculopathies resulting in pain secondary to failed back syndrome; 3) post laminectomy pain; 4) unsuccessful disk surgery; 5) degenerative disk disease (ddd)/herniated disk pain refractory to conservative and surgical interventions; 6) peripheral causalgia; 7) epidural fibrosis; 8) arachnoiditis or lumbar adhesive arachnoiditis; 9) complex regional pain syndrome (crps) or reflex sympathetic dystrophy (rsd) or causalgia; and 10) multiple back surgeries.
-
-